OLIGOCREATOR

Licensing of industrial property rights arising from scientific research services in the field of biochemistry [excluding the field of cell culture products], nucleic acids and bioinformatics, in particular molecular biology techniques, especially antisense techniques; licensing of industrial property rights arising from the design of pharmaceutical active ingredients by means of the aforementioned processes and techniques, including the use of bioinformatics techniques; licensing of industrial property rights arising from the development of pharmaceutical products by means of the aforementioned processes and techniques, including the use of bioinformatics techniques, including the performance of associated testing and diagnostic procedures; licensing of industrial property rights arising from bioinformatic services for the pharmaceutical and biotechnological industry; licensing of industrial property rights arising from the services for evaluating the efficacy and safety of pharmaceutical products.

Scientific research services in the field of biochemistry [excluding the field of cell culture products], nucleic acids and bioinformatics, in particular molecular biology techniques, especially antisense techniques; design of pharmaceutical active ingredients by means of the aforementioned processes and techniques, including the use of bioinformatics techniques; development of pharmaceutical products by means of the aforementioned processes and techniques, including the use of bioinformatics techniques, including the performance of associated testing and diagnostic procedures; bioinformatic services for the pharmaceutical and biotechnological industry; services for evaluating the efficacy and safety of pharmaceutical products.

Consultancy services to third parties in the field of biochemistry and nucleic acids and bioinformatics, including antisense technology, in relation to the development of pharmaceutical products; consultancy services to third parties in relation to the evaluation of safety and efficacy of pharmaceuticals.